Temperature changes in vitrectomy

Article

Examining the temperature changes in the vitreous and retina and possible side effects

"Therapeutic hypothermia is being used more and more throughout medicine these days, with many benefits, but also with some possible bad side effects," he continued. "We determined that that we are in fact inducing hypothermia to the retina and vitreous during vitrectomy with unknown (but probably minimal) side effects."

Effect of temperature

"Fortunately," Dr Landers added, "using room temperature infusion fluid during a victrectomy, which induces hypothermia in the retina and vitreous (and probably other structures inside the eye, such as the lens) seems to have minimal side effects."

One of the main concerns and side effects of vitrectomy is cataract. "Many patients undergoing a vitrectomy develop a cataract in their lens sooner than in their nonvitrectomized eye. We don't know the reason for this. It is just possible that it is somehow related to the induced hypothermia... but this is still speculative," he explained.

The study

This prospective study, however, included only six patients and Dr Landers emphasized a need for further research to fully examine what possible effects this change in temperature could have. "Ideally, a larger and longerterm study shoud be performed, possibly even a controlled study that compares the effects of room temperature infusion fluid and warmer, possibly body temperature, infusion fluid to see if the warmed fluid produces fewer cataracts," Dr Landers said. "We are continuing our measurements to obtain larger data sets and we are also testing differing conditions, such as retinal detachments and other situations."

Special contributor

Dr Reece Landers, MD, is a vitreoretinal surgeon at the University of North Carolina, Chapel Hill, North Carolina, USA. He may be reached by Email: maurice_landers@med.unc.edu

Dr Landers has no financial interests in the subject matter.

Reference

1. M.B. Landers 3rd et al., Retina, 2012; 32(1):172–176.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.